Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Paper
  • Published:

TNF-α protects dendritic cells from prostate cancer-induced apoptosis

Prostate Cancer and Prostatic Diseases volume 4, pages 221–227 (2001)Cite this article

Abstract

We have recently shown that human prostate cancer (PCa) cells induced apoptotic death of the most potent antigen-presenting cells, dendritic cells (DC), which are responsible for the induction of specific antitumor immune responses. Here we have evaluated the effect of murine PCa cells RM-1 on the survival of immature and tumor necrosis factor-α (TNF-α)-stimulated mature DC. PCa cells and DC were co-incubated for 24–48 h and DC apoptosis was assessed by morphologic criteria, Annexin V assay, and TUNEL staining. We have shown that co-incubation of RM-1 cells with DC is accompanied by an increased level of DC apoptosis, which was mediated by decreased expression of anti-apoptotic protein Bcl-2. Stimulation of DC maturation by TNF-α resulted in increased resistance of DC to PCa-induced apoptosis. In TNF-α treated mature DC, but not in immature DC, the expression of Bcl-2 was not blocked after exposure to RM-1-derived factors. Thus, these data suggest that TNF-α-induced maturation of DC increases their resistance to PCa induced apoptosis. This is likely to be due to the stabilizing of the expression of anti-apoptotic protein Bcl-2. The difference in the sensitivity of mature and immature DC to PCa-induced cell death should be considered during the design of DC-based clinical trials for PCa patients.

.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Bander NH et al MHC class I and II expression in prostate carcinoma and modulation by interferon-alpha and -gamma. Prostate 1997 33 233–239

    Article  CAS  Google Scholar 

  2. Herr HW Suppressor cells in immunodepressed bladder and prostate cancer patients. J Urol 1980 123 635–639

    CAS  PubMed  Google Scholar 

  3. Salgaller ML et al Report of immune monitoring of prostate cancer patients undergoing T-cell therapy using dendritic cells pulsed with HLA-A2-specific peptides from prostate-specific membrane antigen (PSMA). Prostate 1998 35 144–151

    Article  CAS  Google Scholar 

  4. Pirtskhalaishvili G et al Cytokine-mediated Protection of human dendritic cells from prostate cancer-induced apoptosis is regulated by the Bcl-2 family of proteins. Br J Cancer 2000 83 506–513

    Article  CAS  Google Scholar 

  5. Shurin MR Dendritic cells presenting tumor antigen. Cancer Immunol Immunother 1996 43 158–164

    Article  CAS  Google Scholar 

  6. Becker Y Anticancer role of dendritic cells (DC) in human and experimental cancers—A review. Anticancer Res 1992 12 511–520

    CAS  PubMed  Google Scholar 

  7. Shurin GV, Yurkovetsky ZR, Shurin MR Tumor-induced dendritic cell dysfunction. In: Ochoa A (ed). Mechanisms of Tumor Escape Harwood Academic Publishers 2001 in press

    Google Scholar 

  8. Pirtskhalaishvili G, Shurin MR Dendritic cells in the treatment of prostate cancer. Cancer Res Alert 2000 1 89–91

    Google Scholar 

  9. Aalamian M et al Human prostate cancer regulates generation and maturation of monocyte-derived dendritic cells. Prostate 2001 46 68–75

    Article  CAS  Google Scholar 

  10. Esche C et al CD154 inhibits tumor-induced apoptosis in dendritic cells and tumor growth. Eur J Immunol 1999 29 2148–2155

    Article  CAS  Google Scholar 

  11. Muller R, Marmenout A, Fiers W Synthesis and maturation of recombinant human tumor necrosis factor in eukaryotic systems. FEBS Lett 1986 197 99–104

    Article  CAS  Google Scholar 

  12. Carswell EA et al An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA 1975 72 3666–3670

    Article  CAS  Google Scholar 

  13. Pennica D et al Human tumor necrosis factor: precursor structure, expression and homology to lymphotoxin. Nature 1984 312 724–729

    Article  CAS  Google Scholar 

  14. Spies T et al Genes for the tumor necrosis factors alpha and beta are linked to the human major histocompatibility complex. Proc Natl Acad Sci USA 1986 83 8699–702

    Article  CAS  Google Scholar 

  15. Matthews N Tumor-necrosis factor from the rabbit. V. Synthesis in vitro by mononuclear phagocytes from various tissues of normal and BCG-injected rabbits. Br J Cancer 1981 44 418–424

    Article  CAS  Google Scholar 

  16. Vassalli P The pathophysiology of tumor necrosis factors. Ann Rev Immun 1992 10 411–452

    Article  CAS  Google Scholar 

  17. Chen B et al The role of tumor necrosis factor alpha in modulating the quantity of peripheral blood-derived, cytokine-driven human dendritic cells and its role in enhancing the quality of dendritic cell function in presenting soluble antigens to CD4+T-cells in vitro Blood 1998 91 4652–4661

    CAS  PubMed  Google Scholar 

  18. Lutz MB et al An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immun Meth 1999 223 77–92

    Article  CAS  Google Scholar 

  19. Shurin MR Regulation of dendropoiesis in cancer. Clin Immunol Newsletter 1999 19 135–139

    Article  Google Scholar 

  20. Shurin MR et al FLT3 ligand induces the generation of functionally active dendritic cells in mice. Cell Immunol 1997 179 174–184

    Article  CAS  Google Scholar 

  21. Kerr JF, Wyllie AH, Currie AR Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972 26 239–257

    Article  CAS  Google Scholar 

  22. Murphy G et al Phase I clinical trial: T-cell therapy for prostate cancer using autologous dendritic cells pulsed with HLA-A0201-specific peptides from prostate-specific membrane antigen. Prostate 1996 29 371–380

    Article  CAS  Google Scholar 

  23. Murphy GP et al Infusion of dendritic cells pulsed with HLA-A2-specific prostate-specific membrane antigen peptides: a phase II prostate cancer vaccine trial involving patients with hormone-refractory metastatic disease. Prostate 1999 38 73–78

    Article  CAS  Google Scholar 

  24. Troy A, Davidson P, Atkinson C, Hart D Phenotypic characterisation of the dendritic cell infiltrate in prostate cancer. J Urol 1998 160 214–219

    Article  CAS  Google Scholar 

  25. Bigotti G, Coli A, Castagnola D Distribution of Langerhans cells and HLA class II molecules in prostatic carcinomas of different histopathological grade. Prostate 1991 19 73–87

    Article  CAS  Google Scholar 

  26. Banchereau J, Steinman RM Dendritic cells and the control of immunity. Nature 1998 392 245–252

    Article  CAS  Google Scholar 

  27. Shurin MR, Esche C, Lokshin A, Lotze MT Apoptosis in dendritic cells. In: Lotze MT, Thomson AW (eds). Dendritic Cells: Biology and Clinical Applications Academic Press: San Diego 1999 673–692

    Google Scholar 

  28. Rath PC, Aggarwal BB TNF-induced signaling in apoptosis. J Clin Immunol 1999 19 350–364

    Article  CAS  Google Scholar 

  29. Mannel DN, Echtenacher B TNF in the inflammatory response. Chem Immunol 2000 74 141–161

    Article  CAS  Google Scholar 

  30. Ludewig B et al Spontaneous apoptosis of dendritic cells is efficiently inhibited by TRAP (CD40-ligand) and TNF-alpha, but strongly enhanced by interleukin-10. Eur J Immunol 1995 25 1943–1950

    Article  CAS  Google Scholar 

  31. Josien R et al TRANCE, a TNF family member, is differentially expressed on T cell subsets and induces cytokine production in dendritic cells. J Immunol 1999 162 2562–2568

    CAS  PubMed  Google Scholar 

  32. Caux C, Dezutter-Dambuyant C, Schmitt D, Banchereau J GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells. Nature 1992 360 258–261

    Article  CAS  Google Scholar 

  33. Zhang Y et al Induction of dendritic cell differentiation by granulocyte-macrophage colony-stimulating factor, stem cell factor, and tumor necrosis factor alpha in vitro from lineage phenotypes-negative c-kit+murine hematopoietic progenitor cells. Blood 1997 90 4842–4853

    CAS  PubMed  Google Scholar 

  34. Santiago-Schwarz F, Belilos E, Diamond B, Carsons SE TNF in combination with GM-CSF enhances the differentiation of neonatal cord blood stem cells into dendritic cells and macrophages. J Leuk Biol 1992 52 274–281

    Article  CAS  Google Scholar 

  35. Brand U et al Influence of extracellular matrix proteins on the development of cultured human dendritic cells. Eur J Immunol 1998 28 1673–1680

    Article  CAS  Google Scholar 

  36. Riedl E, Strobl H, Majdic O, Knapp W TGF-beta 1 promotes in vitro generation of dendritic cells by protecting progenitor cells from apoptosis. J Immunol 1997 158 1591–1597

    CAS  PubMed  Google Scholar 

  37. Buelens C et al Human dendritic cell responses to lipopolysaccharide and CD40 ligation are differentially regulated by interleukin-10. Eur J Immunol 1997 27 1848–1852

    Article  CAS  Google Scholar 

  38. Dahlen E, Dawe K, Ohlsson L, Hedlund G Dendritic cells and macrophages are the first and major producers of TNF-alpha in pancreatic islets in the nonobese diabetic mouse. J Immunol 1998 160 3585–3593

    CAS  PubMed  Google Scholar 

  39. Cumberbatch M, Kimber I Tumor necrosis factor-alpha is required for accumulation of dendritic cells in draining lymph nodes and for optimal contact sensitization. Immunol 1995 84 31–35

    CAS  Google Scholar 

  40. Roake J et al Dendritic cell loss from nonlymphoid tissues after systemic administration of lipopolysaccharide, tumor necrosis factor, and interleukin 1. J Exp Med 1995 181 2237–2247

    Article  CAS  Google Scholar 

  41. Pulliam L, Zhou M, Stubblebine M, Bitler CM Differential modulation of cell death proteins in human brain cells by tumor necrosis factor alpha and platelet activating factor. J Neurosci Res 1998 54 530–538

    Article  CAS  Google Scholar 

  42. Spanaus KS, Schlapbach R, Fontana A TNF-alpha and IFN-gamma render microglia sensitive to Fas ligand-induced apoptosis by induction of Fas expression and down-regulation of Bcl-2 and Bcl-xL. Eur J Immunol 1998 28 4398–4408

    Article  CAS  Google Scholar 

  43. Sallusto F, Lanzavecchia A Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 1994 179 1109–1118

    Article  CAS  Google Scholar 

  44. Thurnher M et al In vitro generation of CD83+human blood dendritic cells for active tumor immunotherapy. Exp Hematol 1997 25 232–237

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This study was funded by RO1 CA80126 (to MRS), RO1 CA84270 (to MRS), The Pittsburgh Foundation for Medical Research (to MRS and GP), and the DOD DAMD17-00-1-0099 P1832735 (to MRS).

Author information

Authors and Affiliations

  1. Department of Urology, University of Pittsburgh Medical Center, University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA

    G Pirtskhalaishvili

  2. Department of Pathology, University of Pittsburgh Medical Center, University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA

    GV Shurin, C Esche & MR Shurin

  3. Department of Medicine, University of Pittsburgh Medical Center, University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA

    DL Trump

Authors
  1. G Pirtskhalaishvili
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. GV Shurin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C Esche
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. DL Trump
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. MR Shurin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to MR Shurin.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pirtskhalaishvili, G., Shurin, G., Esche, C. et al. TNF-α protects dendritic cells from prostate cancer-induced apoptosis. Prostate Cancer Prostatic Dis 4, 221–227 (2001). https://doi.org/10.1038/sj.pcan.4500525

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.pcan.4500525

Keywords

This article is cited by

Search

Advanced search

Quick links